← Back to Search

CBGT+ABMT(active) for Generalized Anxiety Disorder

N/A
Waitlist Available
Led By Gisele G Manfro, MD, PhD
Research Sponsored by Hospital de Clinicas de Porto Alegre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary diagnosis of Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SeAD) or Social Anxiety Disorder (SoAD) according to KSADS-PL psychiatric interview
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up endpoint (week-10) and 6-month follow-up
Awards & highlights

Study Summary

The objective of this project is to test the combination of active or placebo Attentional Bias Modification Treatment (ABMT) to either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for anxiety disorders in children.

Eligible Conditions
  • Generalized Anxiety Disorder
  • Separation Anxiety Disorder
  • Social Anxiety Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~endpoint (week-10) and 6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and endpoint (week-10) and 6-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Global Impression - Improvement Scale (CGI-I) / dichotomous
Pediatric Anxiety Rating Scale (PARS) / continuous
Secondary outcome measures
Biological measures
Childhood Depression Inventory (CDI)
Neuropsychological measures
+3 more

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: PCI+ABMT(active)Experimental Treatment2 Interventions
Group II: CBGT+ABMT(placebo)Experimental Treatment2 Interventions
Group III: CBGT+ABMT(active)Experimental Treatment2 Interventions
Group IV: PCI+ABMT(placebo)Placebo Group2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Behavioral Group Therapy
2016
Completed Phase 4
~620

Find a Location

Who is running the clinical trial?

Hospital de Clinicas de Porto AlegreLead Sponsor
440 Previous Clinical Trials
175,237 Total Patients Enrolled
3 Trials studying Generalized Anxiety Disorder
320 Patients Enrolled for Generalized Anxiety Disorder
Gisele G Manfro, MD, PhDPrincipal InvestigatorFederal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre
1 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Generalized Anxiety Disorder
60 Patients Enrolled for Generalized Anxiety Disorder
Silvia H Koller, PhDPrincipal InvestigatorFederal University of Rio Grande do Sul / University of Psychology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children
2011. "Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01687764.
All > Anxiety Disorder > Anxiety
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top